These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3827603)

  • 21. Relative bioavailability and release pattern of whole and halved sustained-release theophylline tablets.
    Leeds NH; Gal P; Purohit AA; Walter JB
    Clin Pharm; 1982; 1(2):163-4. PubMed ID: 7185516
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies on the pharmacokinetics of theophylline in asthmatic patients following multiple oral dosing of a sustained-release theophylline tablet formulation.
    Takagi K; Yamaki K; Satake T; Hasegawa T; Ogura Y; Suzuki R; Mizukami Y
    Arerugi; 1985 Nov; 34(11):1006-14. PubMed ID: 4084062
    [No Abstract]   [Full Text] [Related]  

  • 23. Absorption of theophylline from conventional and sustained-release tablets.
    Mellstrand T; Svedmyr N; Fagerström PO
    Eur J Respir Dis Suppl; 1980; 109():54-60. PubMed ID: 6934088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the pharmacokinetics of theophylline and its effect on respiratory impedance in asthmatic patients after multiple oral dosing of a sustained-release theophylline tablet formulation.
    Takagi K; Nosaka H; Satake T; Hasegawa T; Ogura Y; Mizukami Y
    Arerugi; 1986 May; 35(5):320-8. PubMed ID: 3753206
    [No Abstract]   [Full Text] [Related]  

  • 25. Bioavailability of two Soviet sustained-release theophylline formulations in comparison with TheoDur.
    Kiivet RA; Teder P; Pruunsild T; Svensson JO
    Pharmacol Toxicol; 1992 Nov; 71(5):388-90. PubMed ID: 1448452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Galenical development of a new sustained-release theophylline pellet formulation for once-daily administration.
    Benedikt G; Steinijans VW; Dietrich R
    Arzneimittelforschung; 1988 Aug; 38(8A):1203-9. PubMed ID: 3190808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absorption of sustained-release theophylline tablets.
    Fagerström PO; Heintz L
    Int J Clin Pharmacol Ther Toxicol; 1983 Jul; 21(7):359-62. PubMed ID: 6885207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacokinetics and biologic availability of a new theophylline sustained-release preparation].
    Brüller W; Fischer M; Tritthart W
    Arzneimittelforschung; 1985; 35(12):1854-9. PubMed ID: 4096745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison of circadian variation of serum theophylline concentration and bioavailability between Theo-dur tablet and a new sustained-release theophylline formulation (E-0686 granule)].
    Kishida M; Okuma M; Uekusa T; Akimoto K; Obata T; Akazawa A; Odajima Y; Nagakura T; Iikura Y; Hukushima K
    Arerugi; 1988 Apr; 37(4):218-25. PubMed ID: 3228360
    [No Abstract]   [Full Text] [Related]  

  • 30. Differences in steady-state plasma levels between aminophylline and theophylline sustained-release micropellets after repeated circadian dosing.
    Schulz HU; Steinijans VW; Gabel H
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):621-5. PubMed ID: 6500759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioavailability of sustained-release theophylline granules in apple sauce in pediatric asthmatic patients.
    Lotner GZ; Vanderpool GE; Carroll S; Tinkelman DG; Spangler DL
    Ann Allergy; 1983 Jan; 50(1):27-9. PubMed ID: 6849516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Release, absorption and elimination of theophylline from fast and slowly released oral formulations].
    Frömming KH; Schwabe L; Staib AH; Rietbrock N; Lassmann A; Molz KH; Schuppan D; Siebert-Weigel M; Voegele D
    Arzneimittelforschung; 1983; 33(3):446-52. PubMed ID: 6683521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Studies on the sustained-release theophylline tablet].
    Mao FF; Tu XD; Zhu JB; Zhu YP
    Yao Xue Xue Bao; 1986 Mar; 21(3):213-9. PubMed ID: 3788587
    [No Abstract]   [Full Text] [Related]  

  • 34. Influence of food on the rate and extent of absorption of theophylline after single dose oral administration of a controlled release tablet.
    Lagas M; Jonkman JH
    Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):424-6. PubMed ID: 4044074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of capsicum fruit on theophylline absorption and bioavailability in rabbits.
    Bouraoui A; Toumi A; Ben Mustapha H; Brazier JL
    Drug Nutr Interact; 1988; 5(4):345-50. PubMed ID: 3240714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Absorption profile and absolute bioavailability of a theophylline sustained-release preparation].
    Pabst G; Weber W; Barkworth MF; Müller M; Rehm KD
    Arzneimittelforschung; 1998 May; 48(5A):574-9. PubMed ID: 9676347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [In vivo testing of a peroral theophylline depot preparation with zero-order release].
    Lippold BC; Förster H
    Arzneimittelforschung; 1984; 34(7):824-9. PubMed ID: 6541919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study on the influence of food on the absorption of theophylline from a controlled-release preparation.
    Pabst G; Weber W; Müller M; Barkworth MF
    Arzneimittelforschung; 1994 Mar; 44(3):333-7. PubMed ID: 8192698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bioavailability of 3 theophylline delayed-release preparations. Comparison of theophylline concentrations in the serum and saliva in the steady state].
    Bochsler HP; Meyer UA
    Schweiz Med Wochenschr; 1982 Nov; 112(47):1702-10. PubMed ID: 7178872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative pharmacokinetic analysis of a novel sustained-release dosage form of theophylline in humans.
    Raz I; Bialer M; Salame K; Bar-On H
    Eur J Clin Pharmacol; 1984; 26(3):401-3. PubMed ID: 6734702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.